Some dietary factors exacerbate symptoms or contribute to inflammation
External Validity Evidence from the SELECT trial addressed the evidence gap on the effects of semaglutide 2.4 mg on CV outcomes, which was raised in the previous submission for the weight management indication, but only for a subset of patients in the indicated population
To evaluate the effects of compound on GPX4 activity, compound was first pre-incubated with purified GPX4 in the assay buffer [Tris-HCl (100 mM, pH 7.4), EDTA (5 mM), Triton X-100 (0.1% v/v), NADPH (0.2 mM), glutathione (3 mM), and glutathione reductase (1 unit)] for 5 min at 37C
Its inclusion allows research to extend into the subsequent phase, investigating how the initial GH signal is translated into cellular actions related to growth, repair, and adaptation over a prolonged period
Cariou, B., Zar, Y., Staels, B